Its a genuinely multi-purpose detox supplement simultaneously binding toxins, providing antioxidant protection, and supplying the micronutrients that power detox pathways
Both medications are GLP-1 receptor agonists, but they work differently enough that it may affect your overall results
The colitis associated with high-dose (10 mg/kg) ipilimumab and the combination regimen is generally more severe and has a quicker onset than that associated with PD-1 inhibitor monotherapy
Both medications may stave off chronic diseases associated with obesity, including hypertension, sleep apnea, and certain cancers
Water retention, muscle gain from new exercise, hormonal fluctuations, and GI changes from the medication itself can all mask real progress in the short term